250 related articles for article (PubMed ID: 35416088)
1. Carbon footprint and associated costs of asthma exacerbation care among UK adults.
Kponee-Shovein K; Marvel J; Ishikawa R; Choubey A; Kaur H; Thokala P; Ngom K; Fakih I; Schatzki T; Signorovitch J
J Med Econ; 2022; 25(1):524-531. PubMed ID: 35416088
[TBL] [Abstract][Full Text] [Related]
2. Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation.
Kponee-Shovein K; Marvel J; Ishikawa R; Choubey A; Kaur H; Ngom K; Fakih I; Swartz N; Schatzki T; Signorovitch J
J Med Econ; 2022; 25(1):940-953. PubMed ID: 35686860
[TBL] [Abstract][Full Text] [Related]
3. Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study.
Alzaabi A; Bell JP; Montero-Arias F; Price DB; Jackson DJ; Wang HC; Budgen N; Farouk H; Maslova E
Adv Ther; 2023 Nov; 40(11):4836-4856. PubMed ID: 37684493
[TBL] [Abstract][Full Text] [Related]
4. Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries.
Pernigotti D; Stonham C; Panigone S; Sandri F; Ferri R; Unal Y; Roche N
BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34872967
[TBL] [Abstract][Full Text] [Related]
5. Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England.
Wilkinson AJK; Braggins R; Steinbach I; Smith J
BMJ Open; 2019 Oct; 9(10):e028763. PubMed ID: 31662306
[TBL] [Abstract][Full Text] [Related]
6. Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study.
Wilkinson AJK; Maslova E; Janson C; Radhakrishnan V; Quint JK; Budgen N; Tran TN; Xu Y; Menzies-Gow A; Bell JP
Thorax; 2024 Feb; 79(5):412-21. PubMed ID: 38413192
[TBL] [Abstract][Full Text] [Related]
7. Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) Programme.
Wilkinson A; Maslova E; Janson C; Xu Y; Haughney J; Quint JK; Budgen N; Menzies-Gow A; Bell J; Crooks MG
Adv Ther; 2022 May; 39(5):2270-2280. PubMed ID: 35279810
[TBL] [Abstract][Full Text] [Related]
8. Carbon footprint impact of the choice of inhalers for asthma and COPD.
Janson C; Henderson R; Löfdahl M; Hedberg M; Sharma R; Wilkinson AJK
Thorax; 2020 Jan; 75(1):82-84. PubMed ID: 31699805
[TBL] [Abstract][Full Text] [Related]
9. [Reduction of greenhouse gas emissions by inhaler choice in the therapy of asthma and COPD patients].
Bickhardt J; Czupalla C; Bader U
Pneumologie; 2022 May; 76(5):321-329. PubMed ID: 35453159
[TBL] [Abstract][Full Text] [Related]
10. Impact of Asthma Inhalers on Global Climate: A Systematic Review of Their Carbon Footprint and Clinical Outcomes in Spain.
Montoro J; Antolín-Amérigo D; Izquierdo-Domínguez A; Zapata JJ; González G; Valero A
J Investig Allergol Clin Immunol; 2023 Jul; 33(4):250-262. PubMed ID: 36648318
[TBL] [Abstract][Full Text] [Related]
11. Can we minimize carbon footprint by using "greener" inhalers and improve clinical outcome at the same time in asthma therapy?
Płusa T; Badowska-Kozakiewicz A
Pol Merkur Lekarski; 2021 Aug; 49(292):252-254. PubMed ID: 34464363
[TBL] [Abstract][Full Text] [Related]
12. Estimating the national carbon footprint of inhalers in healthcare.
Owens S; Morris K; Hurley E; O'Reilly K; O'Callaghan J; Allman J; Linehan D; McDonald M; Green S
Ir J Med Sci; 2023 Oct; 192(5):2251-2253. PubMed ID: 36482282
[TBL] [Abstract][Full Text] [Related]
13. Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis.
Gagné M; Karanikas A; Green S; Gupta S
BMJ Open Respir Res; 2023 Sep; 10(1):. PubMed ID: 37730281
[TBL] [Abstract][Full Text] [Related]
14. Turning green: the impact of changing to more eco-friendly respiratory healthcare - a carbon and cost analysis of Dutch prescription data.
Ten Have P; van Hal P; Wichers I; Kooistra J; Hagedoorn P; Brakema EA; Chavannes N; de Heer P; Ossebaard HC
BMJ Open; 2022 Jun; 12(6):e055546. PubMed ID: 35701064
[TBL] [Abstract][Full Text] [Related]
15. Thinking "Green" When Treating "Pink Puffers" and "Blue Bloaters"-Reducing Carbon Footprint When Prescribing Inhalers.
Holman HT; Bouthillier MJ; Müller F
J Am Board Fam Med; 2023 Apr; 36(2):356-359. PubMed ID: 36801847
[TBL] [Abstract][Full Text] [Related]
16. A case study of the carbon footprint of milk from high-performing confinement and grass-based dairy farms.
O'Brien D; Capper JL; Garnsworthy PC; Grainger C; Shalloo L
J Dairy Sci; 2014 Mar; 97(3):1835-51. PubMed ID: 24440256
[TBL] [Abstract][Full Text] [Related]
17. Assessment of organizational carbon footprints in a denim-washing company: a systematic approach to indirect non-energy emissions.
Aykaç Özen H; Vayiç B; Çoruh S
Environ Sci Pollut Res Int; 2024 May; 31(24):35897-35907. PubMed ID: 38740688
[TBL] [Abstract][Full Text] [Related]
18. The environmental impact of inhalers for asthma: A green challenge and a golden opportunity.
Wilkinson A; Woodcock A
Br J Clin Pharmacol; 2022 Jul; 88(7):3016-3022. PubMed ID: 34719810
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
20. Local variation in low carbon footprint inhalers in pre-COVID pandemic primary care prescribing guidelines for adult asthma in England and its potential impact.
Twigg AJ; Wilkinson A; Smith JN
Br J Clin Pharmacol; 2022 Dec; 88(12):5083-5092. PubMed ID: 36002398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
